Stefan Irion

2.3k total citations · 1 hit paper
16 papers, 1.2k citations indexed

About

Stefan Irion is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, Stefan Irion has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Surgery. Recurrent topics in Stefan Irion's work include Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (7 papers) and Biomedical Ethics and Regulation (4 papers). Stefan Irion is often cited by papers focused on Pluripotent Stem Cells Research (12 papers), CRISPR and Genetic Engineering (7 papers) and Biomedical Ethics and Regulation (4 papers). Stefan Irion collaborates with scholars based in United States, Canada and Japan. Stefan Irion's co-authors include Gordon Keller, Marica Gršković, Radbod Darabi, John T. Dimos, Rita C. R. Perlingeiro, Michael Kyba, Robert W. Arpke, Hervé Luche, Paul Gadue and Hans Jörg Fehling and has published in prestigious journals such as Nature, Immunity and Nature Biotechnology.

In The Last Decade

Stefan Irion

16 papers receiving 1.2k citations

Hit Papers

Phase I trial of hES cell-derived dopaminergic neurons fo... 2025 2026 2025 5 10 15 20 25

Peers

Stefan Irion
Eungi Yang United States
Michaela Patterson United States
Sunita L. D’Souza United States
Stefan Irion
Citations per year, relative to Stefan Irion Stefan Irion (= 1×) peers Marica Gršković

Countries citing papers authored by Stefan Irion

Since Specialization
Citations

This map shows the geographic impact of Stefan Irion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Irion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Irion more than expected).

Fields of papers citing papers by Stefan Irion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Irion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Irion. The network helps show where Stefan Irion may publish in the future.

Co-authorship network of co-authors of Stefan Irion

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Irion. A scholar is included among the top collaborators of Stefan Irion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Irion. Stefan Irion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tabar, Viviane, Harini Sarva, Andrés M. Lozano, et al.. (2025). Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease. Nature. 641(8064). 978–983. 25 indexed citations breakdown →
2.
Kim, Tae Wan, Jinghua Piao, So Yeon Koo, et al.. (2021). Biphasic Activation of WNT Signaling Facilitates the Derivation of Midbrain Dopamine Neurons from hESCs for Translational Use. Cell stem cell. 28(2). 343–355.e5. 118 indexed citations
3.
Irion, Stefan. (2019). Cell Therapies for Parkinson's Disease. Clinical and Translational Science. 12(2). 95–97. 7 indexed citations
4.
Wilkinson, Dan & Stefan Irion. (2019). Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture. Cell and Gene Therapy Insights. 5(1). 85–96. 6 indexed citations
5.
Irion, Stefan, Susan E. Zabierowski, & Mark Tomishima. (2016). Bringing Neural Cell Therapies to the Clinic: Past and Future Strategies. Molecular Therapy — Methods & Clinical Development. 4. 72–82. 23 indexed citations
6.
Kreiner, Thane & Stefan Irion. (2013). Whole-Genome Analysis, Stem Cell Research, and the Future of Biobanks. Cell stem cell. 12(5). 513–516. 7 indexed citations
7.
Darabi, Radbod, Robert W. Arpke, Stefan Irion, et al.. (2012). Human ES- and iPS-Derived Myogenic Progenitors Restore DYSTROPHIN and Improve Contractility upon Transplantation in Dystrophic Mice. Cell stem cell. 10(5). 610–619. 341 indexed citations
8.
Loh, Yuin‐Han, Odelya Hartung, Li Hu, et al.. (2010). Reprogramming of T Cells from Human Peripheral Blood. Cell stem cell. 7(1). 15–19. 221 indexed citations
9.
Irion, Stefan, Raedun Clarke, Hervé Luche, et al.. (2010). Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells. Development. 137(17). 2829–2839. 58 indexed citations
10.
Kubo, Atsushi, Yon Hui Kim, Stefan Irion, et al.. (2009). the Homeobox Gene Hex Regulates Hepatocyte Differentiation From Embryonic Stem Cell–Derived Endoderm. Hepatology. 51(2). 633–641. 32 indexed citations
11.
Kasuda, Shogo, Akiharu Kubo, Yoshihiko Sakurai, et al.. (2008). Establishment of embryonic stem cells secreting human factor VIII for cell‐based treatment of hemophilia A. Journal of Thrombosis and Haemostasis. 6(8). 1352–1359. 21 indexed citations
12.
Irion, Stefan, M. Cristina Nostro, Steven Kattman, & Gordon Keller. (2008). Directed Differentiation of Pluripotent Stem Cells: From Developmental Biology to Therapeutic Applications. Cold Spring Harbor Symposia on Quantitative Biology. 73(0). 101–110. 54 indexed citations
13.
Irion, Stefan, Hervé Luche, Paul Gadue, et al.. (2007). Identification and targeting of the ROSA26 locus in human embryonic stem cells. Nature Biotechnology. 25(12). 1477–1482. 232 indexed citations
14.
Irion, Stefan, Rance E. Berg, & Uwe D. Staerz. (2000). A Physiological Ligand of Positive Selection Is Seen with High Specificity. The Journal of Immunology. 164(9). 4601–4606. 4 indexed citations
15.
Berg, Rance E., et al.. (2000). A Physiological Ligand of Positive Selection Is Recognized as a Weak Agonist. The Journal of Immunology. 165(8). 4209–4216. 8 indexed citations
16.
Berg, Rance E., et al.. (1999). Positive Selection of an H2-M3 Restricted T Cell Receptor. Immunity. 11(1). 33–43. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026